Hypertension in pregnant women
Journal Title: Przewodnik Lekarza - Year 2006, Vol 83, Issue 1
Abstract
Prevalence of hypertension in pregnancy is approximately 5-10%. It appears to be one of more important causes of obstetric complications. Hypertension in pregnancy is recognized when blood pressure values are ≥140/90 mm Hg. Classification of hypertension in pregnancy includes: 1) chronic hypertension determined before 20 weeks of gestation; 2) pregnancy induced hypertension-determined after 20 weeks of gestation; when it is associated with proteinuria ≥300 mg per day we recognize preeclampsia; when features of intravascular hemolysis, liver damage and low platelet count are present we recognize HELLP syndrome; this state increases maternal and child mortality risk, particulary when eclampsia is overlapped; 3) pregnancy induced hypertension overlapped on chronic hypertension – when worsening of disease after 20 weeks of gestation is noticed; 4) late (transient) hypertension appears in perinatal period. The treatment of hypertension in pregnancy require special observation and close collaboration between patient and doctor. Non-pharmacological management is sufficient when blood pressure values not exceed 150/100 mmHg. In other cases we must consider pharmacological therapy with medication safe for child. After delivery verification of diagnosis and treatment is necessary.
Authors and Affiliations
Aleksandra Rutz-Danielczak
Keywords
Related Articles
- EP ID EP159816
- DOI -
- Views 65
- Downloads 0
Venous thromboembolism
Venous thromboembolism (VTE) is one of the most important problems of contemporary medicine. It is connected with the fact, that this disease is common and in the case of the adverse effect of deep vein thrombosis, can...
Acute and chronic rhinosinusitis - treatment
Authors present latest opinions about the pathogenesis of rhinosinusitis, the symptomatolgy, diagnostic tools and therapeutic methods. Both the acute and chronic rhinusinusitis are discussed.
Strategia leczenia jaskry
W pracy przedstawiono współczesne poglądy na patogenezę różnych postaci jaskry i związane z tym indywidualne podejście do leczenia. Pokrótce przedstawiono metody diagnostyczne oraz ich zastosowanie do monitorowania lecze...
Statyny w leczeniu chorób układu krążenia. Niewydolność serca
Statyny są najsilniejszymi lekami obniżającymi stężenie cholesterolu LDL-C. W wielu badaniach klinicznych udowodniono, że leczenie statynami zmniejsza ryzyko choroby wieńcowej i zgonu z jej powodu, a także ryzyko udaru...
Ochrona przed powikłaniami
Nowe dane z Brigham and Women’s Hospital przedstawione na Kongresie Europejskiego Towarzystwa Kardiologicznego w 2005 r. dowodzą, że rozpoczęcie podawania klopidogrelu przed interwencją wieńcową pozwala na uniknięcie po...